Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

A new study links urinary metabolites from organophosphorus pesticides to increased age-related macular degeneration risk.

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

FYB203 has been approved by the US FDA and UK Medicines and Healthcare products Regulatory Agency for the treatment ...

Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

European Commission approves Eylea 8 mg with extended 6-month treatment interval for nAMD and visual impairment due to DME: Berlin Saturday, June 28, 2025, 09:00 Hrs [IST] The Eur ...

Bengaluru: Biocon Biologics Ltd ., a fully integrated global biosimilars company and a subsidiary of Biocon Ltd ., has ...